Concepedia
Statistics
Publications
23
Citations
701
H-Index
18
Active since
1987
Affiliations
Uppsala University(Current)
Karolinska Institutet
Merck & Co., Inc., Rahway, NJ, USA (United States)
Novartis (Switzerland)
Novartis (Sweden)
Jan Stålhammar is an author at Uppsala University specializing in medicine, cardiovascular disease, and diabetes mellitus.
Publications per year
1987–2021
Prevalence and incidence of Type 2 diabetes and its complications 1996–2003—estimates from a Swedish population‐based study
Anna Ringborg, Peter Lindgren, Mats Martinell et al. · Diabetic Medicine · 2008 · 77 citations
Medicine, Endocrinology, Health Sciences +11
Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
Sverre E. Kjeldsen, Jan Stålhammar, Pål Hasvold et al. · Journal of Human Hypertension · 2009 · 61 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes
Anna Ringborg, Peter Lindgren, Dangyue Yin et al. · Diabetes & Metabolism · 2010 · 52 citations
Medicine, Endocrinology, Internal Medicine +12
Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data
Anna Ringborg, Mats Martinell, Jan Stålhammar et al. · International Journal of Clinical Practice · 2008 · 51 citations
Pharmacy, Internal Medicine, Healthcare Economics +16
Prescription drug use among diabetics—A population study
Dag Isacson, Jan Stålhammar · Journal of Chronic Diseases · 1987 · 48 citations
Pharmacy, Pharmacotherapy, Pharmacy Practice +12
1–5 of 23